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Abstract
Stepwise synthesis of monodisperse polyethylene glycols (PEGs) and their
derivatives usually involves using an acid-labile protecting group such as DMTr and
coupling two PEG moieties together under the basic Williamson ether formation
conditions. Using this approach, each elongation of PEG is achieved in three steps –
deprotection, deprotonation, and coupling – in two pots. Here, we report a more
convenient approach for PEG synthesis featuring the use of a base-labile protecting group
such as the phenethyl group. Using this approach, each elongation of PEG can be
achieved in only two steps – deprotection and coupling – in one pot. The deprotonation
step and the isolation and purification of the intermediate product after deprotection using
existing approaches are not needed when the new one-pot approach is used. Because
stepwise PEG synthesis usually requires multiple PEG elongation cycles, the new PEG
synthesis method is expected to significantly lower PEG synthesis cost and reduce the
use of harmful solvents and other chemicals.

x

Chapter 1 Background
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1.1 Introduction
This thesis is based on my work in Dr. Fang's laboratory. The focal point is on the
multi-step synthesis of Polyethylene glycols (PEGs) using a base-labile protecting group
and its application in making longer PEGs. The beginning of the work consisted of
making a monomer and using it to systematically build PEG compounds by a
bidirectional approach to become longer using Williamson ether formations. This chapter
is an introduction to that work, focusing on what PEG is and its application in the world
of chemistry, and how it is produced.

1.2 PEG and Its Applications
PEGs are polymer compounds that can come in different sizes of ethylene glycol
units (Figure 1.1.). These compounds have physical and chemical properties that have a
stable, flexible, and neutral backbone. The compound is also soluble in water and many
other organic solvents. This range of properties allows it to be a gold standard for
biopharmaceuticals and various other applications. 1

O
HO

n

OH

Figure 1.1. A structural representation of PEG.
PEGylation is the process of coupling PEG to biomolecules. PEGylation helps to
improve solubility and stability as well as to decrease immunogenicity and dosing
2

frequency in biomacromolecules.2 Other applications of PEGs consist of being used as
linkers in organic synthesis, ingredients in nanomedicines that are used to stabilize
nanoparticles and assist cell entry.5 Moreover, they are used to evade undesired immune
responses during drug delivery. PEGs are also being used as drug carriers for the new
COVID-19 mRNA vaccines.4

1.3 Known Methods for Mono-dispersed PEG Synthesis
The simple method for producing PEGs is the polymerization of ethylene oxide.
The drawback of this method is that it makes PEGs with admixtures of length and
molecular weights.7 Purification and separation of these polydisperse PEGs is impossible,
so often, it is characterized, weighted, and numbered by its average molecular weight.8
When preparing drugs, if there are polydisperse PEGs, there can be a problem in having a
consistent composition, which is essential for delivering the drug into the body. This
heterogeneity can cause a loss in biological activities to result in different chemical and
physical properties. These drawbacks make polydisperse PEG not preferred in drug
delivery.
There has been a high demand for mono-dispersed PEG compounds as future
crosslinking agents for biomolecules. The advantages of these mono-dispersed PEGs are
their uniform size and distinct structure, which is highly important in the pharmaceutical
industry.3 This causes the uniformation of the PEG chain to be valuable for the drug
registration process.
Although, PEGs are structurally simple molecules. They are a challenge to
synthesize. One of the main challenges dealing with depolymerization occurs when a
3

deprotonated PEG reacts with itself by undergoing anionic depolymerization to produce
ethylene oxide, the depolymerized product of PEG. (Scheme 1.1). After
depolymerization, it is practically impossible to separate the depolymerized PEG by any
purification techniques.
O

RO

O

RO

O

O

Scheme 1.1. Representation of the depolymerization of PEG
Over the years, research groups around the world have been developing ways to
make PEG more uniform. One of the ways for synthesizing uniform PEG is stepwise
solution-phase synthesis. Most methods undergo Williamson ether formation reaction.
This synthetic route typically begins when an alkylating agent containing a leaving group
reacts with an alkoxide ion. The common leaving groups used today for this synthesis are
primary halides and alkyl sulfonates, such as chloride (–Cl), bromide (–Br),
methanesulfonate (or mesyl, –OMs), and toluenesulfonate (or tosyl, –Ts).9
Using the Williamson ether synthetic method, there have been various strategies in
producing high purity monodispersed PEGs.1-3, 6-8 The common strategies used today for
mono-dispersed PEG synthesis are unidirectional and bidirectional PEG elongation.9
In unidirectional PEG elongation, it builds upon one side of the polymer (Scheme
1.2.). The PEG compound relies on two protecting groups (PG) and a leaving group (Lg).
4

When comparing the two PGs, one is temporary, where the other is short-term throughout
the synthetic cycle. The temporary PG is removed to extend the PEG further using a
monomer of n-length in which has an Lg and the temporary PG. When undergoing this
route, the short-term PG needs to be stable under conditions when removing the
temporary PG. This process is repeated to achieve the desired PEG chain length.
However, often unidirectional PEG elongation is not used for long-chain PEG elongation

5

because of its inferior strategy to grow the polymer. Still, rather it is used as a monomer
for other methods such as bidirectional PEG elongation.9

PG2(PEG)nOH

HO(PEG)nOH

PG2(PEG)nLg

PG1(PEG)nOH

PG1(PEG)n+nPG2

PG1(PEG)2nOH

PG1(PEG)2n+nPG2

PG1(PEG)3nOH

PG1(PEG)3n+nPG2

Repeat of Steps

Scheme 1.2. Representation of unidirectional PEG elongation

In bidirectional PEG elongation, it involves extending the PEG on both sides of the
chain (Scheme 1.3.). Unlike unidirectional PEG elongation, bidirectional extension relies
6

on a temporary PG rather than a short-term PG.9 This allows PEG chain growth to
increase two times faster, superior to the unidirectional route. One disadvantage this
method has is that both sides of the product now have the same functionality. Moreover,
this is the most commonly used strategy to make long-chain PEGs.1, 3, 10, 11
PG1(PEG)nOH

HO(PEG)nOH

PG1(PEG)nLg

PG1(PEG)n+2nPG1

HO(PEG)3nOH

PG1(PEG)3n+2nPG1

HO(PEG)5nOH

PG1(PEG)5n+2nPG1

Repeated steps

Scheme 1.3. Representation of bidirectional PEG elongation.
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A typical synthetic pathway for the bidirectional approach uses an acid-labile
protecting group such as 4,4’-dimethoxytriphenylmethyl (DMTr-) as the temporary PG
and using -OTs as the Lg. The pathway goes through three steps: deprotonation,
coupling, and deprotection. These steps occur in two pots in which yield
homobifuctionalized DMTrO(PEG)n+2nODMTr.8 This process is repeated to yield longer
PEGs. However, as the PEG becomes longer, removing the DMTr- group becomes more
difficult because the deprotection of the DMTr- is reversible. Another issue is that the
reaction is difficult to complete when doing on a large scale.
The drawbacks of these multi-step synthetic strategies, such as the random
polymerization of ethylene oxide, are not ideal for pharmaceutical applications. The
difficulties for the unidirectional and bidirectional PEG elongation methods have
problems as PEGs become longer. This is caused by the low efficiency of Williamson
ether formation from the large size of the compound. Another problem is the need for
multiple column chromatography uses to purify monomers, intermediates, and the final
product, which entails heavy use of solvents.

1.4 One-Pot PEG Synthesis
In this thesis, I am going to describe a new method for the synthesis of
monodisperse PEGs. A monomer with a base-labile protecting group instead of an acidlabile protecting group is used in this method. With monomers having a base-labile
protection group, PEG elongation is achieved in two steps – deprotection and coupling in
only one pot (Scheme 2.1.). There is no need to isolate and purify the intermediate
between deprotection and coupling, and the deprotonation step is not needed. Our results
8

show that the synthesis is significantly more convenient than known methods, and high
quality of monodisperse PEGs can be obtained in acceptable to high yields.
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Chapter 2

PEG Synthesis Featuring PEG Elongation in One Pot
By
Logan Mikesell, Adikari Mudiyanselage Dhananjani Nisansala Eriyagama, Yipeng Yin,
Bao-Yuan Lu, and Shiyue Fang
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2.1 Introduction
Polyethylene glycols and derivatives (PEGs) have found wide applications in many
areas.1-6 For some applications, polydisperse PEGs are acceptable, although those with
narrow molecular weight distribution are almost always desirable. These PEGs can be
synthesized conveniently by polymerization of ethylene oxide under basic or acidic
conditions.7 The polymerization methods are inexpensive, and PEGs with high molecular
weight can be obtained. However, for many other applications, which include as linkers
in organic synthesis and bioconjugation,8 as ingredients in nanomedicines to stabilize
nanoparticles and to assist nanoparticle cell entry,9-11 and as PEGylation agents to
stabilize drugs based on biologic molecules such as peptides, proteins, and nucleic acids
and to evade undesired immune responses, monodisperse PEGs are required or highly
desirable.12, 13

Scheme 2.1. A comparison of the new PEG synthesis method using a base-labile
protecting group with known PEG synthesis methods using an acid-labile protecting
group.
13

To meet the needs of monodisperse PEGs, many efforts have been made to develop
stepwise methods for their synthesis.14-26 Perhaps, the most widely used method in
academia and in the industry involves using a monomer such as compound 1, which
contains the acid-labile DMTr protecting group. PEG elongation is achieved by
deprotection under acidic conditions, purifying the intermediate, and setting up separate
reactions to carry out the deprotonation and Williamson ether formation reactions under
basic conditions (Scheme 2.1.).17, 19, 20, 22, 26 In this letter, we report the use of monomers
containing a base-labile protecting group such as 2 with the phenethyl group for stepwise
monodisperse PEG synthesis. With monomers having a base-labile protection group,
PEG elongation is achieved in two steps – deprotection and coupling in only one pot
(Scheme 2.1). There is no need to isolate and purify the intermediate between
deprotection and coupling, and the deprotonation step is not needed. Our results show
that the synthesis is significantly more convenient than known methods, and high quality
of monodisperse PEGs can be obtained in acceptable to high yields.

14
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Scheme 2.2. Screening base-labile protecting groups for stepwise PEG synthesis.

2.2 Results and Discussion
For a base-labile protecting group to be helpful in PEG synthesis using the one-pot
PEG elongation approach, it needs to meet two criteria: (1) The protecting group can be
removed under basic conditions. (2) The protecting group is stable under the basic
Williamson ether formation conditions. For this reason, we screened several potentially
functional protecting groups against these two criteria using compounds 3a-l.
For criterium (1), we subjected the compounds to basic conditions and used TLCs
to monitor the progress of the 1,2-elimination (3a-j) or 1,4-elimination (3k-l) reactions.
Initially, compound 3a (1 equiv.) was treated with LDA (1 equiv.) with a catalytic
15

amount of tBuOK (0.2 equiv.) in THF at -78 oC.27, 28 Complete consumption of 3a to give
methoxide and styrene was observed after warming the reaction mixture to -50 oC and
stirring at the temperature for less than two hours. Because LDA has a short shelf life and
has to be stored at low temperature, we were curious if (TMS)2NK (pKa of conjugate
acid, 26), which is a weaker base than LDA (pKa of conjugate acid, 36)29 and can be
stored at room temperature for a long period of time, could also bring about the reaction.
Surprisingly, we found that the reaction occurred with high efficiency even without using
any catalysts. Therefore, (TMS)2NK was used for screening the rest of the compounds
(3b-j). Gratifyingly, all the compounds underwent 1,2-elimination (3b-i) or 1,4elimination (3j) readily using this weaker base, and according to TLC, the reactions had
100% conversion after stirring at 0 oC for less than two hours (appendix A, Figures A.1.A.12.). Thus, we concluded that all the protecting groups in compounds 3a-j meet
criterium (1).
For criterium (2), we conducted the Williamson ether formation reaction between
compounds 4 and 1 to form compound 5 using KN(TMS)2 as the base in the presence of
compounds 3a-j. Compound 4 (1 equiv.) in THF was deprotonated with KN(TMS)2 (1.2
equiv.). The mixture was cooled to -78 oC, and the solution of 1 (1.5 equiv.) and 3a-i or
3j (1.5 equiv.) in THF was added. The reaction mixture was warmed to room temperature
gradually, and then heated to 60 oC. TLC analysis was performed to determine if the
product 5 could be formed without causing the elimination reaction of 3. The addition of
excess base for the deprotonation of 4 was to ensure complete deprotonation in the event
of inadvertent moisture. Cooling the solution of the deprotonated 4 to low temperature
before addition of 1 and 3 and gradually warming the mixture to room temperature before
16

heating was to prevent the removal of the base-labile protecting group in 3 by the excess
strong base by allowing the excess base to be consumed selectively via β-elimination of
the tosylate in 1. The product of premature removal of the base-labile protecting group –
an alkoxide – would complicate the reaction, while the product of β-elimination of the
tosylate – a vinyl ether – is inert under the reaction conditions. Compounds 3a-j were
subjected to the study. All were found to be stable under the coupling conditions, while
product 5 was formed as indicated by TLC analysis (appendix A, Figures A.13 – A.24.).
Therefore, we concluded that all the protecting groups in compounds 3a-j meet criterium
(2) under the conditions used for the screening studies.
Among the groups studied, the phenethyl group (the -(CH2)2Ph group) is one of
the simplest. In addition, when the proposed one-pot PEG elongation approach is used for
the synthesis of long PEGs, higher temperature and longer reaction time are usually
needed for the Williamson ether formation reaction.17 This requires the protecting groups
to be stable under conditions harsher than those used in our screening studies. Therefore,
it is preferable to choose a relatively more stable group than a less stable one for the onepot PEG elongation application. Among the groups studied, the phenethyl group belongs
to the more stable ones. With these considerations, the phenethyl group was chosen for
the development of the one-pot PEG elongation approach for PEG synthesis.
The required monomer is 2. The simplest method for its synthesis would be to
react (PEG)4, which is commercially available and inexpensive, with styrene to give 6,30
and tosylation of 6 to give the monomer (Scheme 2.3). However, the reported conditions
for the synthesis of 6 without using an expensive catalyst gave low yields. We did not test
17

the conditions using the expensive catalyst that was used in the literature30 due to cost
considerations in practical applications although there is a possibility to obtain acceptable
yields under those conditions. Another method we tried was to react excess
TsO(PEG)4OTs with 2-phenylethan-1-ol under basic conditions to give 2 (Scheme 2.3).
However, separation of 2 from TsO(PEG)4OTs and TsO(PEG)4O(CH2)2Ph required
extensive chromatography. Thus, this method had been put aside. In our lab, we can
produce 1 in large quantities without any chromatography,26 and therefore, we decided to
use a route for the synthesis of 2 using 1 as the starting material. As shown in Scheme
2.3, 2-phenylethan-1-ol was reacted with 1 under basic conditions to give 7. Removal of
the DMTr group of 7 under acidic conditions gave 6. Tosylation of 6 under reported
conditions gave 2. This route is longer than the other two, but the products of all the steps
are easy to purify, and it is our preferred route.

HO

O

3

OH

(PEG)4
TsO

O

OTs

3

TsO(PEG)4OTs

HO(CH2)2Ph

HO

O
6

styrene
base

HO

1)oNaH, DMF
0 C to rt

2

DMTrO

2) 1, DMF
60 oC, 24 h

3

O(CH2)2Ph

3

O(CH2)2Ph

6 low yield

HO(CH2)2Ph
base

O

THF, H2O

O

3

7

O(CH2)2Ph

2

Scheme 2.3. Synthesis of monomer 2.
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With the monomer 2 in hand, the stepwise synthesis of monodisperse PEG using
the one-pot elongation approach was investigated using the route in Scheme 4. The
commercially available and inexpensive (PEG)4 was deprotonated with excess NaH and
reacted with monomer 2. This gives the (PEG)12 derivative 8. The next reactions can
elegantly show the convenience of the one-pot PEG elongation approach. The phenethyl
groups in 8 was removed with KN(TMS)2 and the intermediate alkoxide was reacted
directly with 2 in one pot to give the (PEG)20 derivative 9. The same procedure was
simply repeated to give PEG derivatives Ph(CH2)2O(PEG)28O(CH2)2Ph (10),
Ph(CH2)2O(PEG)36O(CH2)2Ph (11), and Ph(CH2)2O(PEG)44O(CH2)2Ph (12). In the PEG
elongation process, we used excess KN(TMS)2 (2.5 equiv.) for the deprotection to
overcome inadvertent moisture. To prevent the excess base from deprotecting the
phenethyl groups in the monomer, before adding the monomer, the reaction mixture was
cooled to -78 oC, and then the monomer solution was added, and the reaction mixture was
warmed to room temperature slowly before heating the 60 oC. The careful manipulation
of the temperature allowed the excess base to be selectively consumed via β-elimination
of the tosylate of the monomer instead of removing its protecting group. As noted earlier,
the side product of β-elimination of the tosylate does not affect the reaction while the side
product of premature deprotection of the monomer would cause problems. The yields of
the one-pot PEG elongation reactions were not optimized. They ranged from 25% to
86%. We believe that the yields can be improved by careful reaction workup and product
purification, which is especially true for long PEG synthesis when the relatively
hydrophobic phenethyl groups in the molecules are less capable to curtail the
hydrophilicity of PEG moiety and to bring the product to organic phase during aqueous
19

workup. We also believe that the one-pot approach can be readily adopted for the
synthesis of PEGs longer then (PEG)44. Two facts are supportive of this speculation. One
is that PEG depolymerization did not appear to be a significant problem according to MS
(appendix A).31 The other is that according to TLC (appendix A), the PEG products we
made were not difficult to purify, and it is reasonable to predict that PEGs significantly
longer than the ones we made will behave similarly.

(PEG)4

1)oNaH, THF
0 C, 30 min
o

2) 2, 60 C, 24 h

Ph(CH2)2O(PEG)12O(CH2)2Ph

Ph(CH2)2O(PEG)20O(CH2)2Ph
9
1) KN(TMS)2
-78 oC to 0 oC
o

2) 2, 60 C, 24 h

8
1) KN(TMS)2
-78 oC to 0 oC
o

2) 2, 60 C, 24 h

o

2) 2, 60 C, 24 h

Ph(CH2)2O(PEG)28O(CH2)2Ph

Ph(CH2)2O(PEG)36O(CH2)2Ph
11

1) KN(TMS)
2
-78 oC to 0 oC

10
1) KN(TMS)
2
-78 oC to 0 oC
o

2) 2, 60 C, 24 h

Ph(CH2)2O(PEG)44O(CH2)2Ph
12

Scheme 2.4. PEG synthesis using the one-pot PEG elongation approach.
The major advantage of using a base-labile protecting group such as the phenethyl
group for stepwise monodisperse PEG synthesis is reducing the PEG elongation process
from three steps in two pots to two steps in one pot. There is no need to isolate and purify
the intermediate product after the deprotection step using the new approach. Because
stepwise PEG synthesis requires repeating the PEG elongation process multiple times,
shortening the process can make PEG synthesis significantly more convenient and
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monodisperse PEG potentially much more affordable. In the literature, besides the DMTr
group, other protecting groups, including benzyl and silyl groups, have also been used for
PEG synthesis.16, 19, 23, 25 However, like the DMTr group, when they were used, all
required three steps – deprotection, deprotonation and coupling – in two pots for each
PEG elongation. Therefore, the base-labile group is not only a better choice than the
DMTr group, but also a better choice than any known protecting groups.
In addition to shortening the PEG elongation process from two pots to one pot,
the base-labile protecting group is also easier to remove than other protecting groups. For
example, the reaction to remove the DMTr group is reversible, and thus the reaction is
difficult to complete when it is carried out at large scales. It is also reported that
removing the group from PEGs can become more and more difficult as PEGs become
longer.17 For removing the benzyl group, palladium is usually needed for the
hydrogenation reaction. Palladium is expensive, and more problematically, it is difficult
to remove from the product.16, 25 In contrast, the base-labile groups can be removed with
an environmentally benign base at 0 oC, and the reaction is irreversible and fast.30
The discovery that KN(TMS)2 can efficiently remove phenethyl and other groups
at 0 oC is remarkable. In the literature, the presentiment suggested by data is that a strong
base is needed for the reaction, and even with a base as strong as LDA, tBuOK has to be
used to catalyze the reaction. Otherwise, the reaction would not occur. Our finding that
KN(TMS)2 alone can remove the phenethyl group and other groups is remarkable
because this base is significantly less basic than LDA, and its solution in toluene and
THF can be stored at room temperature for long period of time. In contrast, LDA has to
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be stored at low temperatures and has a short lifetime. Usually, freshly preparing them
before each use is preferred by most chemists.
There are several different routes for stepwise monodisperse PEG synthesis.19 The
base-labile protecting strategy can be easily incorporated into all those routes, and the
routes can be shortened significantly by carrying out deprotection and coupling in one
pot. We demonstrated the convenience of the one-pot PEG elongation approach using the
route in Scheme 2.3. This route has the advantage of using the same monomer in each
elongation cycle. In addition, the length of the monomer is significantly shorter than that
of the product, and therefore, excess monomer can be used to drive the PEG elongation
reactions to completion because the excess monomer can be easily removed from the
product using chromatography. However, for the synthesis of PEGs longer than (PEG)60
or asymmetric PEGs, routes using two different protecting groups such as the phenethyl
and DMTr groups involving converting DMTrO(PEG)nO(CH2)2Ph, where n is an integer,
to HO(PEG)nO(CH2)2Ph and then to TsO(PEG)nO(CH2)2Ph, and coupling
DMTrO(PEG)nO(CH2)2Ph with TsO(PEG)nO(CH2)2Ph in one pot to give
DMTrO(PEG)2nO(CH2)2Ph would be preferred. This route can make the length of the
PEG double in each elongation cycle and the PEG product is asymmetric.
It is noted that the use of base-labile protecting groups or linkers in organic
synthesis involving carrying out reactions under less basic reactions and removing the
protecting group or cleaving the linker under more basic conditions is not common. In
contrast, the use of acid-labile protecting groups or linkers involving carrying out
reactions under less acidic conditions and removing the protecting group or cleaving the
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linker under more acidic conditions is more frequently adopted. For example, in peptide
synthesis, the trityl group can be selectively removed under acidic conditions in the
presence of the acid-sensitive BAL linker,32 the Boc group can be selectively removed in
the presence of the acid-sensitive PAM linker,33 and protected peptides can be cleaved
from the acid-labile 2-chlorotrityl resin with dilute TFA without affecting acid-labile
side-chain protecting groups.34 In solid-phase RNA synthesis, the acid-sensitive 2'-TOM
protecting groups can survive the acidic conditions for removing the 5'-DMTr groups.35
The one-pot PEG elongation approach using a base-labile protecting group is feasible
only if there is a large difference between the pKa of the hydroxyl group of PEG and that
of the hydrogen in the protecting group that is needed to be removed by a base to initiate
the deprotection via β-elimination. The pKa of the hydroxyl group of PEG is less than 15,
while that of the β-hydrogen in the phenethyl group is probably over 40. The large
difference between the pKa values ensures that the base-labile protecting group is stable
under the basic Williamson ether formation reaction conditions. While the pKa of the βhydrogen in the phenethyl group is over 40, β-elimination during deprotection can still
occur readily at 0 oC even with the relatively weak base KN(TMS)2, the conjugated acid
of which has a pKa of only 26.29 The reasons for this to happen may be attributed to the
irreversibility of the β-elimination reaction, the low kinetic barrier of the reaction, and
probably the inaccuracy of the pKa values as pKa values vary widely under different
conditions.

2.3 Conclusion
In summary, a one-pot PEG elongation approach has been developed for stepwise
monodisperse PEG synthesis. By using a base-labile protecting group such as the
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phenethyl group instead of the commonly used groups such as the acid-labile DMTr
group, the deprotection and coupling steps in PEG synthesis can be carried out in one pot
instead of two pots. The deprotonation step is not needed using the new approach. In
addition, due to the irreversibility of the reactions for their deprotection, the new
protecting groups are also easier to remove. Our results showed that the PEG synthesis
method is convenient to execute, and acceptable to high yields of PEG products can be
obtained. We expect that the one-pot PEG elongation approach will be helpful to make
monodisperse PEGs more affordable and have a positive impact in areas where
monodisperse PEGs are needed.

2.4 Experimental Section
General information: All compounds from commercial sources were used as received
unless noted otherwise. THF was distilled over Na/benzophenone under nitrogen.
Compounds 3d,37 3e,38 3g39 and 3j39 were synthesized following reported procedure. All
reactions were carried out under nitrogen using oven-dried glassware. Thin layer
chromatography (TLC) was performed using Sigma-Aldrich TLC plates, silica gel 60F254 over glass support, 250 μm thickness. 1H and 13C NMR spectra were obtained on a
Varian UNITY INOVA spectrometer at 400 and 100 MHz, respectively. Chemical shifts
(δ) were reported in reference to solvent peaks (residue CHCl3 at δ 7.24 ppm for 1H and
CDCl3 at δ 77.00 ppm for 13C). HRMS was obtained on a Thermo HR-Orbitrap Elite
Mass Spectrometer. LRMS was obtained on a Thermo Finnigan LCQ Advantage Ion
Trap Mass Spectrometer.
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Screening base-labile protecting groups for PEG synthesis – Testing if the groups in 3a-l
can be removed under basic conditions: In an oven dried 25 mL flask, 3a-k or 3l (0.734
mmol, 1 equiv.) was dissolved in THF (4 mL). The solution was cooled to -78 oC.
KN(TMS)2 (1 M in THF, 1.4 mL, 1.468 mmol, 2 equiv.) was added via a syringe. The
reaction mixture was stirred while warming to 0 oC gradually. After 2 h, TLC analyses
(see supporting information) were carried out. All compounds 3a-l were found to be
consumed. Thus, the base-labile protecting groups in them meet the criterium of being
deprotectable under basic conditions required for PEG synthesis. Compound 3a was also
tested using the base tBuOK/LDA and found deprotectable under the conditions.27, 28
Screening base-labile protecting groups for PEG synthesis – Testing the stability of
protecting groups under the basic Williamson ether formation conditions: Compounds
DMTrO(PEG)4OTs (1)26 and MeO(PEG)4OH (4) were dried over P2O5 in a desiccator
under vacuum for 2 days. Compound 4 (41 mg, 0.201 mmol, 1 equiv.) was dissolved in
THF (200 µL) under nitrogen. The solution was cooled to -78 oC, and KN(TMS)2 (0.241
mL, 1 M in THF, 1.2 equiv.) was added dropwise via a syringe. After addition, the
reaction flask was placed in an ice bath for ~30 min. The mixture was then cooled to -78
o

C. The solution of 1 (195 mg, 0.301 mmol, 1.5 equiv.) and 3a-k or 3l (0.301 mmol, 1.5

equiv.) in THF (500 µL) was added via a cannula dropwise over ~1 min. The reaction
mixture was warmed to rt gradually over ~3 h. After stirring at rt for ~30 min, the
mixture was heated to 60 oC and stirred vigorously at the temperature for 24 h. TLC
analyses (see supporting information) were carried out to determine if the Williamson
ether formation reaction could proceed to form product 5 without any consumption of the
compound 3a-k or 3l. All the compounds were found to be able to survive the basic
25

Williamson ether formation reaction conditions. Thus, the base-labile protecting groups
in them meet the criterium of being stable under basic coupling conditions required for
PEG synthesis.
DMTrO(PEG)4O(CH2)2Ph (7): The suspension of NaH (60% in mineral oil, 716 mg,
17.92 mmol, 2.5 equiv.) in anhydrous DMF (25 mL) in a 1 L 2-neck round bottom flask
under nitrogen was cooled on an ice bath. The solution of Ph(CH2)2OH (2.14 mL, 17.92
mmol, 2.5 equiv.) in anhydrous DMF (15 mL) was added dropwise via a cannula over ~1
h. After addition, the reaction mixture was stirred at 0 °C for ~1 h. The ice bath was
removed. This gave the solution of NaO(CH2)2Ph. Compound 1 (contaminated with
DMTrO(PEG)4ODMTr; total 4.66 g; assumed 7.17 mmol as if it were pure, 1 equiv.),
which had been dried over P2O5 under high vacuum overnight, was dissolved in
anhydrous DMF (15 mL). The solution was added to the solution of NaO(CH2)2Ph
dropwise via a cannula. After addition, the mixture was stirred vigorously at 60 oC for 24
h. After cooling to rt, the reaction was quenched with EtOH. DMF was removed on a
rotary evaporator under high vacuum. The residue was partitioned between EtOAc (250
mL) and 5% K2CO3 (100 mL). The organic phase was washed with 5% K2CO3 (100 mL
× 3), dried over anhydrous Na2SO4, and filtered. The filtrate was evaporated to dryness
under reduced pressure and further dried under high vacuum. The residue was purified
with flash chromatography (SiO2, 10% Et3N/hexanes) to give compound 7 (4.02 g,
95.6%), as a yellow oil: TLC Rf = 0.3 (SiO2, hexanes/EtOAc 3:1); 1H NMR (400 MHz,
CDCl3) δ 7.49-7.47 (d, 2H), 7.37-7.35 (d, 4H), 7.29-7.18 (m, 8H), 6.83-6.80 (m, 4H),
2.76-2.69 (m, 8H), 3.74 (s, 6H), 3.68-3.59 (m, 16H), 3.25-3.23 (t, 2H), 2.91-2.87 (t, 2H);
13

C NMR (100 MHz, CDCl3) δ 158.5, 145.3, 139.1, 136.5, 130.3, 129.1, 128.5, 128.4,
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127.9, 126.8, 126.3, 113.2, 86.2, 72.6, 71.0, 70.5, 63.5, 55.5, 36.6; HRMS (ESI) calcd for
C37H43O7Na [M+Na]+ 623.2985, found 623.2971.
Ph(CH2)2O(PEG)4 (6): Compound 7 (2.17 g, 3.62 mmol, 1 equiv.) was dissolved in dry
DCM (10 mL). To the solution was added TFA (433 µL, 3.62 mmol, 1 equiv.). The
reaction mixture was stirred vigorously. After ~5 mins, TLC indicated that compound 7
was consumed. The reaction was quenched with solid NaOH and low quantity of water
until pH ~9. The mixture was then partitioned between DCM (total about 200 mL) and
brine (75 mL). The aqueous phase was washed with DCM (100 mL x 3). The combined
organic phase was dried over anhydrous Na2SO4, and filtered. The filtrate was evaporated
to dryness, and the residue was purified with flash chromatography (SiO2, EtOAc) to give
compound 6 (568 mg, 77.4%) as a yellow oil: TLC Rf = 0.10 (SiO2, hexanes/EtOAc 1:3);
1

H NMR (400 MHz, CDCl3) δ 7.25-7.10 (m, 5H), 3.67-3.64 (t, 2H), 3.62-3.53 (m, 16H),

2.87-2.83 (t, 2H); 13C NMR (100 MHz, CDCl3) δ 138.9, 129.1, 128.5, 126.3, 72.8, 70.8,
70.5, 91.9, 36.5; HRMS (ESI) calcd for C16H26O5H [M+H]+ 299.1859, found 299.1847;
C16H26O5Na [M+Na]+ 321.1678, found 321.1662.
Ph(CH2)2O(PEG)4OTs (2): The compound was synthesized using a reported procedure
with modifications.36 The solutions of 6 (9.22 g, 46.5 mmol, 1 equiv.) in THF (50 mL)
and NaOH powder (22.3 g, 558 mmol, 12 equiv.) in water (50 mL) were combined and
stirred at 0 °C for 5 min. The solution of TsCl (26.5 g, 139.5 mmol, 3 equiv.) in THF (50
mL, note that it is important to keep the ratio of total THF and water at around 2:1 v/v)
was added dropwise over 10 min while the reaction mixture was stirred at 0 °C. After
addition, stirring was continued while the temperature was raised to rt gradually. The
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progress of the reaction was monitored by TLC, and complete reaction was observed
within 24 h. The mixture was partitioned between 5% Na2CO3 (300 mL) and EtOAc (500
mL). The aqueous phase was extracted with EtOAc (200 mL × 3). The combined organic
phase was dried over anhydrous Na2SO4 and filtered. Volatiles were removed under
reduced pressure, and the residue was further dried under vacuum from an oil pump.
Compound 2 (12.7 g, 60%) was obtained as a colorless oil after flash chromatography
purification (SiO2, hexanes/EtOAc 1:0 to 2:1): TLC Rf = 0.30 (SiO2, hexanes/EtOAc 1:1);
1

H NMR (400 MHz, CDCl3) δ 7.78-7.76 (d, 2H), 7.32-7.30 (d, 2H), 7.27-7.16 (m, 5H),

4.14-4.12 (t, 2H), 3.68-3.59 (m, 16H), 2.89-2.86 (t, 2H), 2.42 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 144.9, 139.0, 133.2, 129.9, 129.1, 128.5,128.1, 126.3, 72.5, 70.9, 70.8,
70.7, 70.5, 69.5, 68.9, 36.5, 21.9; HRMS (ESI) calcd for C23H31O7SH [M+H]+ 453.1942,
found 453.1953; C23H31O7SNH4 [M+NH4]+ 470.2207, found 470.2216; C23H31O7SNa
[M+Na]+ 474.1761, found 475.1775.
Ph(CH2)2O(PEG)12O(CH2)2Ph (8): Compound 2 (2.19 g, 4.83 mmol, 2.5 equiv.) was
dried over P2O5 under vacuum in a desiccator overnight. A suspension of NaH (60% in
mineral oil, 193 mg, 4.83 mmol, 2.5 equiv.) in dry THF (5 mL) under nitrogen was
cooled on an ice bath. The solution of (PEG)4 (333 µL, 1.93 mmol, 1 equiv.) in dry THF
(10 mL) was added via a cannula dropwise over ~20 min. After addition, the reaction was
allowed to proceed for ~30 min. The ice bath was removed, and compound 2 in THF (10
mL) was added via a cannula dropwise over ~10 min. After addition, the mixture was
stirred vigorously at 60 oC for 24 h. The reaction was quenched with EtOH. THF was
removed under reduced pressure. The residue was partitioned between DCM (100 mL)
and saturated NH4Cl (50 mL). The aqueous phase was washed with DCM (100 mL × 3).
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The combined organic phase was dried over anhydrous Na2SO4 and filtered. The filtrate
was evaporated to dryness, and compound 8 was purified with flash chromatography
(SiO2, EtOAc/MeOH 100:0 to 100:3) to give a colorless oil (1.4 g, 97%): TLC Rf = 0.50
(SiO2, DCM/Et2O/MeOH 3:0.6:0.6); 1H NMR (400 MHz, CDCl3) δ 7.24-7.712 (m, 10H),
3.64-3.55 (m 51H), 2.87-2.83 (t, 4H); 13C NMR (100 MHz, CDCl3) δ 133.9, 129.02,
128.44, 126.28, 72.52, 70.80, 70.90, 36.54 HRMS (ESI) calcd for C40H66O13Na [M+Na]+
777.4401, found 777.4436; C40H66O13Na2 [M+2Na]2+ 400.2150, found 400.2112.
Ph(CH2)2O(PEG)20O(CH2)2Ph (9): Compounds 2 and 8 were dried over P2O5 in a
desiccator under vacuum for 2 days. Compound 8 (1.3 g, 1.8 mmol, 1 equiv.) was
dissolved in dry THF (5 mL) under nitrogen. The solution was cooled to -78 oC, and
KN(TMS)2 (4.6 mL, 1 M in THF, 2.5 equiv.) was added dropwise via a syringe. After
addition, the reaction flask was placed in an ice bath for ~3 h. TLC analysis indicated that
both 8 and Ph(CH2)2O(PEG)12 were not in the reaction mixture. The mixture was then
cooled to -78 oC for ~10 min, and the solution of 2 (3.8 g, 8.3 mmol, 4.5 equiv.) in THF
(10 mL) was added dropwise via a cannula over ~10 min. The reaction mixture was
allowed to warm up to room temperature gradually over a period of ~3 h. After stirring at
room temperature for ~30 min, the mixture was heated to 60 oC and stirred vigorously at
the temperature for 24 h. THF was removed under reduced pressure. The residue was
partitioned between DCM (100 mL) and saturated NH4Cl (20 mL). The aqueous phase
was washed with DCM (100 mL × 3). The combined organic phase was dried over
anhydrous Na2SO4 and filtered. Flash chromatography (SiO2, EtOAc to
DCM/Et2O/MeOH 100:8:4) gave compound 9 (1.765 g, 86%) as a yellow waxy solid:
TLC Rf = 0.40 (SiO2, DCM/Et2O/MeOH 6:0.6:0.6); 1H NMR (400 MHz, CDCl3) δ 7.2829

7.15 (m, 10H), 3.67-3.57 (m 81H), 2.90-2.88 (t, 4H); 13C NMR (100 MHz, CDCl3) δ
138.97, 129.08, 128.50, 126.34, 72.60, 70.80, 70.50, 36.55; HRMS (ESI) calcd for
C56H98O21Na [M+Na]+ 1129.6499, found 1129.6533; C56H98O21H2 [M+2H]2+ 554.3379,
found 554.3390. Compound 9 was also synthesized using tBuOK/LDA instead of
KN(TMS)2 as the base under otherwise identical conditions. Similar yields were
obtained.
Ph(CH2)2O(PEG)28O(CH2)2Ph (10): Synthesized using the procedure for the synthesis of
9. Compound 9 (1.77 g, 1.59 mmol, 1 equiv.) in THF (10 mL), KN(TMS)2 (3.39 mL, 1 M
in THF, 2.5 equiv.), and 2 (3.24 g, 7.15 mmol, 4.5 equiv.) in THF (10 mL) gave the crude
product, which was subjected to aqueous workup and chromatography purification as
describe for 9. Compound 10 (1.6 g, 70%) was obtained as a yellow waxy solid: TLC Rf
= 0.40 (SiO2, DCM/Et2O/MeOH 6:0.6:0.6); 1H NMR (400 MHz, CDCl3) δ 7.27-7.15 (m,
10H), 3.67-3.56 (m 116H), 2.89-2.85 (t, 4H); 13C NMR (100 MHz, CDCl3) δ 139.02,
129.04, 128.46, 126.30, 72.54, 70.80, 36.56; HRMS (ESI) calcd for C74H134O30Na
[M+Na]+ 1481.8596, found 1481.8571; C74H134O30Na2 [M+2Na]2+ 752.4247, found
752.4247; C74H134O30H3 [M+3H]3+ 487.2977, found 487.2971.
Ph(CH2)2O(PEG)36O(CH2)2Ph (11): Synthesized using the procedure for the synthesis of
9. Compound 10 (1.375 g, 0.942 mmol, 1 equiv.) in THF (10 mL), KN(TMS)2 (2.4 mL, 1
M in THF, 2.5 equiv.), and 2 (1.7 g, 3.8 mmol, 4 equiv.) in THF (10 mL) gave the crude
product, which was subjected to aqueous workup and chromatography purification as
describe for 9. Compound 11 (436 mg, 25%) was obtained as a yellow waxy solid: TLC
Rf = 0.40 (SiO2, DCM/Et2O/MeOH 6:0.6:0.6); 1H NMR (400 MHz, CDCl3) δ 7.25-7.15
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(m, 10H), 3.65-3.59 (m 148H), 2.87-2.83 (t, 4H); 13C NMR (100 MHz, CDCl3) δ 139.00,
129.02, 128.44, 126.29, 72.53, 70.79, 70.49, 36.54; HRMS (ESI) calcd for
C88H162O37N2H8 [M+2NH4]2+ 923.5742, found 923.5701; C88H162O37N3H12 [M+3NH4]3+
621.7276, found 621.7269.
Ph(CH2)2O(PEG)44O(CH2)2Ph (12): Synthesized using the procedure for the synthesis of
9. Compound 11 (386 mg, 0.241 mmol, 1 equiv.) in THF (10 mL), KN(TMS)2 (0.532
mL, 1 M in THF, 2.5 equiv.), and 2 (436 mg, 0.964 mmol, 4 equiv.) in THF (10 mL)
gave the crude product, which was subjected to aqueous workup and chromatography
purification as describe for 9. Compound 12 (199 mg, 43%) was obtained as a yellow
waxy solid: TLC, Rf = 0.50 (SiO2, DCM/Et2O/MeOH 6:1:1); 1H NMR (400 MHz,
CDCl3) δ 7.23-7.13 (m, 10H), 3.76-3.38 (m 179H), 2.85-2.81 (t, 4H); 13C NMR (100
MHz, CDCl3) δ 138.95, 129.02, 128.44, 126.29, 72.53, 70.77, 70.47, 36.52; HRMS (ESI)
calcd for C104H194O45N2H8 [M+2NH4]2+ 1099.6790, found 1099.6711; C104H194O45N3H12
[M+3NH4]3+ 739.1308, found 739.1266; C104H194O45N4H16 [M+4NH4]4+ 558.8663, found
558.8548.
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Appendix A. Supporting information for Chapter 2

PEG Synthesis Featuring PEG Elongation in One Pot
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TLC images for screening base-labile protecting groups for PEG synthesis – Testing
if the groups in 3a-l can be removed under basic conditions

Figure A.1. TLC for testing if -(CH2)2Ph group can be deprotected using KN(TMS)2.
Left lane: styrene; middle lane: reaction mixture; right lane: Ph(CH2)2OMe (3a); 2nd and
4th lanes: co-spot of materials spotted on their adjacent lanes. Eluent: hexanes/EtOAc
3:0.5. The TLC indicates that 3a was consumed and styrene was formed.

Figure A.2. TLC for testing if -(CH2)2Ph(4-OMe) group can be deprotected using
KN(TMS)2. Left lane: MeO(CH2)2Ph(4-OMe) (3b); middle lane: co-spot of materials on
the left and right lanes; right lane: reaction mixture. Eluent: hexanes/EtOAc 3:0.5. The
TLC indicates that 3b was consumed.
39

Figure A.3. TLC for testing if -(CH2)2Ph(4-NO2) group can be deprotected by
KN(TMS)2. Left lane: MeO(CH2)2Ph(4-NO2) (3c); middle lane: co-spot of materials on
left and right lanes; right lane: reaction mixture. Eluent: hexanes/EtOAc 3:0.5. The TLC
indicates that 3c was consumed.

Figure A.4. TLC for testing if -(CH2)2Ph(3-F) group can be deprotected by KN(TMS)2.
Left lane: MeO(CH2)2Ph(3-F) (3d); middle lane: co-spot of materials on left and right
lanes; right lane: reaction mixture. Eluent: hexanes/EtOAc 3:1. The TLC indicates that 3d
was consumed.
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Figure A.5. TLC for testing if -(CH2)2-furan group can be deprotected by KN(TMS)2.
Left lane: MeO(CH2)2-furan (3e); middle lane: co-spot of materials on left and right
lanes; right lane: reaction mixture. Eluent: hexanes/EtOAc 2:1. The TLC indicates that 3e
was consumed.

Figure A.6. TLC for testing if -(CH2)2CH=CH2 group can be deprotected by KN(TMS)2.
Left lane: BnO(CH2)2CH=CH2 (3f); middle lane: co-spot of materials on left and right
lanes; right lane: reaction mixture. Eluent: hexanes/EtOAc 9:1. The TLC indicates that 3f
was consumed.
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Figure A.7. TLC for testing if -(CH2)2C≡CMe group can be deprotected by KN(TMS)2.
Left lane: BnO(CH2)2C≡CMe (3g); middle lane, reaction mixture; right lane: BnOH; 2nd
and 4th lanes, co-spot of materials spotted on their adjacent lanes. Eluent: hexanes/DCM
3:1. The TLC indicates that 3g was consumed.

Figure A.8. TLC for testing if -(CH2)2C(=O)NMe2 group can be deprotected by
KN(TMS)2. Left lane: MeO(CH2)2C(=O)NMe2 (3h); middle lane: co-spot of materials on
left and right lanes; right lane: reaction mixture. Eluent: EtOAc. The TLC indicates that
3h was consumed.
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Figure A.9. TLC for testing if -(CH2)2CN can be deprotected by KN(TMS)2. Left lane:
BnOCH2)2CN (3i); middle lane: co-spot of materials on left and right lanes; right lane:
reaction mixture. Eluent: hexanes/EtOAc 3:0.5. The TLC indicates that 3i was consumed.

Figure A.10. TLC for testing if -CH2CH(SCH2)2CH2 group can be deprotected by
KN(TMS)2. Left lane: BnOCH2CH(SCH2)2CH2 (3j); middle lane: co-spot of materials on
the left and right lanes; right lane: reaction mixture. Eluent: hexanes/EtOAc 5:1. The
TLC indicates that 3j was consumed.
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Figure A.11. TLC for testing if -CH2CH=CHMe group can be deprotected by
KN(TMS)2. Left lane: BnOCH2CH=CHMe (3k); middle lane: co-spot of materials on left
and right lanes; right lane: reaction mixture. Eluent: hexanes/EtOAc 9:1. The TLC
indicates that 3k was consumed.

Figure A.12. TLC for testing if -CH2C≡CMe group can be deprotected by KN(TMS)2.
Left lane: EtOCH2C≡CMe (3l); middle lane: co-spot of materials on left and right lanes;
right lane: reaction mixture. Eluent: hexanes/EtOAc 5:1. The TLC indicates that 3l was
consumed.
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TLC images for screening base-labile protecting groups for PEG synthesis – Testing
stability of protecting groups under the basic Williamson ether formation conditions

Figure A.13. TLC for testing the stability of -(CH2)2Ph group under Williamson ether
formation conditions. For all three TLC: left lane, DMTrO(PEG)4OTs (1); middle lane,
reaction mixture; right lane, Ph(CH2)2OMe (3a); 2nd and 4th lanes, co-spot of materials
spotted on their adjacent lanes. Eluent: left TLC, EtOAc/hexanes 1:1; middle TLC,
EtOAc/hexanes 1:3; right TLC, EtOAc/MeOH 3:0.5. Left and middle TLC indicate that
3a was not consumed. Right TLC indicates that DMTrO(PEG)8OMe (5), which has a Rf
of 0.40 and identified with ESI MS, was formed.
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Figure A.14. TLC for testing the stability of -(CH2)2Ph(4-OMe) group under Williamson
ether formation conditions. Left TLC: left lane, MeO(CH2)2Ph(4-OMe) (3b); middle
lane, co-spot of materials on the left and right lanes; right lane, reaction mixture. The
TLC shows that 3b was not consumed. Middle TLC: left lane, DMTrO(PEG)8OMe (5);
middle lane, co-spot of materials on the left and right lanes; right lane, reaction mixture.
The TLC shows that product 5 was formed. Right TLC: left lane, reaction mixture;
middle lane, co-spot of materials on the left and right lanes; righ lane, reaction mixture of
the β-elimination reaction of 3b. The TLC shows that the β-elimination product of 3b
was not formed. Eluent: left TLC, hexanes/EtOAc 3:0.5; middle TLC, EtOAc/MeOH
3:0.5; right TLC, hexanes/EtOAc 3:0.5.
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Figure A.15. TLC for testing the stability of -(CH2)2Ph(4-NO2) group under Williamson
ether formation conditions. Left TLC: left lane, MeO(CH2)2Ph(4-NO2) (3c); middle lane,
co-spot of materials on the left and right lanes; right lane, reaction mixture. The TLC
shows that 3c was not consumed. Middle TLC: left lane, DMTrO(PEG)8OMe (5); middle
lane, co-spot of material on the left and right lanes; right lane, reaction mixture. The TLC
shows that 5 was formed. Right TLC: left lane, reaction mixture; middle lane, co-spot of
materials on the left and right lanes; right lane, reaction mixture of the β-elimination
reaction of 3c. The TLC shows that the β-elimination product of 3c was not formed.
Eluent: left TLC, hexanes/EtOAc 1:1; middle TLC, EtOAc/MeOH 3:1; right TLC,
hexanes/EtOAc 1:1.
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Figure A.16. TLC for testing the stability of -(CH2)2Ph(3-F) group under Williamson
ether formation conditions. Left TLC: left lane, MeO(CH2)2Ph(3-F) (3d); middle lane,
co-spot of materials on the left and right lanes; right lane, reaction mixture. The TLC
shows that 3d was not consumed. Middle TLC: left lane, DMTrO(PEG)8OMe (5); middle
lane, co-spot of material on the left and right lanes; right lane, reaction mixture. The TLC
shows that 5 was formed. Right TLC: left lane, reaction mixture of the β-elimination
reaction of 3d; middle lane, co-spot of materials on the left and right lanes; right lane,
reaction mixture. The TLC shows that the β-elimination product of 3d was not formed.
Eluent: left TLC, hexanes/EtOAc 3:1; middle TLC, EtOAc/MeOH 3:1; right TLC,
hexanes/EtOAc 3:1.
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Figure A.17. TLC for testing the stability of -(CH2)2-furan group under Williamson ether
formation conditions. Left TLC: left lane, MeO(CH2)2-furan (3e); middle lane, co-spot of
materials on the left and right lanes; right lane, reaction mixture. The TLC shows that the
3e was consumed. Right TLC: left lane, DMTrO(PEG)8OMe (5); middle lane, co-spot of
material on the left and right lanes; right lane, reaction mixture. The TLC shows that 5
was formed. Eluent: left TLC, hexanes/EtOAc 2:1; right TLC, EtOAc/MeOH 3:1.
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Figure A.18. TLC for testing the stability of -(CH2)2CH=CH2 group under Williamson
ether formation conditions. Reading from left to right, first TLC: left lane,
BnO(CH2)2CH=CH2 (3f); middle lane, co-spot of materials on the left and right lanes;
right lane, reaction mixture. The TLC shows that 3f was not consumed. Second TLC: left
lane, DMTrO(PEG)8OMe (5); middle lane, co-spot of material on the left and right lanes;
right lane, reaction mixture. The TLC shows that 5 was formed. Third TLC: left lane,
BnOH; middle lane, co-spot of materials on the left and right lanes; right lane, reaction
mixture. The KMnO4 stain is below to further show that β-elimination product was not
formed. Fourth TLC: left lane, reaction mixture of the β-elimination reaction of 3f;
middle lane, co-spot of materials on the left and right lanes; right lane, reaction mixture.
The TLC shows that the β-elimination product of 3f was not formed. The KMnO4 stain is
below to further show that β-elimination product was not formed. Eluent: first TLC,
hexanes/EtOAc 9:1; second TLC, EtOAc/MeOH 3:1; third TLC, hexanes/EtOAc 3:1;
fourth TLC, hexanes/EtOAc 3:1.
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Figure A.19. TLC for testing the stability of -(CH2)2C≡CMe group under Williamson
ether formation conditions. Reading from left to right, first TLC: left lane,
BnO(CH2)2C≡CMe (3g); middle lane, co-spot of materials on the left and right lanes;
right lane, reaction mixture. The TLC shows that 3g was not consumed. Second TLC: left
lane, DMTrO(PEG)8OMe (5); middle lane, co-spot of material on the left and right lanes;
right lane, reaction mixture. The TLC shows that 5 was formed. Third TLC: left lane,
BnOH; middle lane, co-spot of materials on the left and right lanes; right lane, reaction
mixture. The KMnO4 stain is below to further show that β-elimination product was not
formed. Fourth TLC: left lane, reaction mixture of the β-elimination reaction of 3g;
middle lane, co-spot of materials on the left and right lanes; right lane, reaction mixture.
The TLC shows that the β-elimination product of 3g was not formed. The KMnO4 stain is
below to further show that β-elimination product was not formed. Eluent: first TLC,
hexanes/EtOAc 3:1; second TLC, EtOAc/MeOH 3:1; third TLC, hexanes/EtOAc 3:1;
fourth TLC, hexanes/EtOAc 3:1.
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Figure A.20. TLC for testing the stability of -(CH2)2C(=O)NMe2 group under
Williamson ether formation conditions. Left TLC: left lane, MeO(CH2)2C(=O)NMe2
(3h); middle lane, co-spot of materials on the left and right lanes; right lane, reaction
mixture. The TLC shows that the 3h was consumed. Right TLC: left lane,
DMTrO(PEG)8OMe (5); middle lane, co-spot of material on the left and right lanes; right
lane, reaction mixture. The TLC shows that 5 was formed. Eluent: left TLC, acetone;
right TLC, EtOAc/MeOH 3:1.
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Figure A.21. TLC for testing the stability of -(CH2)2CN group under Williamson ether
formation conditions. Left TLC: left lane, BnO(CH2)2CN (3i); middle lane, co-spot of
materials on the left and right lanes; right lane, reaction mixture. The TLC shows that the
3i was not consumed. Right TLC: left lane, DMTrO(PEG)8OMe (5); middle lane, co-spot
of material on the left and right lanes; right lane, reaction mixture. The TLC shows that 5
was formed. Eluent: left TLC, hexanes/EtOAc 3:0.5; right TLC, EtOAc/MeOH 3:0.5.
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Figure A.22. TLC for testing the stability of -CH2CH(SCH2)2CH2 group under
Williamson ether formation conditions. Left TLC: left lane, BnOCH2CH-(SCH2)2CH2
(3j); middle lane, co-spot of materials on the left and right lanes; right lane, reaction
mixture. The TLC shows that 3j was not consumed. Middle TLC: left lane,
DMTrO(PEG)8OMe (5); middle lane, co-spot of materials on the left and right lanes;
right lane, reaction mixture. The TLC shows that 5 was formed. Right TLC: left lane,
reaction mixture of the β-elimination reaction of 3j; middle lane, co-spot of materials on
the left and right lanes; right lane, reaction mixture. The TLC shows that the βelimination product of 3j was not formed. Eluent: left TLC, hexanes/EtOAc 5:1; middle
TLC, EtOAc/MeOH 5:1; right TLC, hexanes/EtOAc 5:1.
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Figure A.23. TLC for testing the stability of -CH2CH=CHMe group under Williamson
ether formation conditions. Reading from left to right, first TLC: left lane,
BnOCH2CH=CHMe (3k); middle lane, co-spot of materials on the left and right lanes;
right lane, reaction mixture. The TLC shows that 3k was not consumed. Second TLC: left
lane, DMTrO(PEG)8OMe (5); middle lane, co-spot of material on the left and right lanes;
right lane, reaction mixture. The TLC shows that 5 was formed. Third TLC: left lane,
BnOH; middle lane, co-spot of materials on the left and right lanes; right lane, reaction
mixture. The KMnO4 stain is below to further show that β-elimination product was not
formed. Fourth TLC: left lane, reaction mixture of the β-elimination reaction of 3k;
middle lane, co-spot of materials on the left and right lanes; right lane, reaction mixture.
The TLC shows that the β-elimination product of 3k was not formed. The KMnO4 stain
is below to further show that β-elimination product was not formed. Eluent: first TLC,
hexanes/EtOAc 9:1; second TLC, EtOAc/MeOH 3:1; third TLC, hexanes/EtOAc 3:1;
fourth TLC, hexanes/EtOAc 3:1.
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Figure A.24. TLC for testing the stability of -CH2C≡CMe group under Williamson ether
formation conditions. Left TLC: left lane, EtOCH2C≡CMe (3l); middle lane, co-spot of
materials on the left and right lanes; right lane, reaction mixture. The TLC shows that
the 3l was not consumed. Right TLC: left lane, DMTrO(PEG)8OMe (5); middle lane, cospot of material on the left and right lanes; right lane, reaction mixture. The TLC shows
that 5 was formed. Eluent: left TLC, hexanes/EtOAc 5:1; right TLC, EtOAc/MeOH 3:1.
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DMTrO(PEG)4O(CH2)2Ph (7)

Figure A.25. TLC of crude 7. Eluent: hexanes/EtOAc 3:2. Left lane, DMTrO(PEG)4OTs
(1); middle lane, co-spot of materials on left and right lanes; right lane, crude 7.

Figure A.26. 1H NMR of Ph(CH2)2O(PEG)4ODMTr (7).
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Figure A.27. 13C NMR of Ph(CH2)2O(PEG)4ODMTr (7).
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Figure A.28. ESI-MS of Ph(CH2)2O(PEG)4ODMTr (7).
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Ph(CH2)2O(PEG)4 (6)

Figure A.29. TLC of crude 6. Eluent: EtOAc/MeOH/hexanes 5:1:0.2. Left lane, purified
6; middle lane, co-spot of materials on left and right lanes; right lane, crude 6.

Figure A.30. 1H NMR of Ph(CH2)2O(PEG)4 (6).
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Figure A.31. 13C NMR of Ph(CH2)2O(PEG)4 (6).
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Figure A.32. ESI-MS of Ph(CH2)2O(PEG)4 (6).
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Ph(CH2)2O(PEG)4OTs (2)

Figure A.33. TLC of crude 2. Eluent: hexanes/EtOAc 1:1. Left lane, purified 2; middle
lane, co-spot of materials on left and right lanes; right lane, crude 2.

Figure A.34. 1H NMR of Ph(CH2)2O(PEG)4OTs (2).
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Figure A.35. 13C NMR of Ph(CH2)2O(PEG)4OTs (2).

Figure A.36. ESI-MS of Ph(CH2)2O(PEG)4OTs (2).
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Ph(CH2)2O(PEG)12O(CH2)2Ph (8)

Figure A.37. TLC of crude 8. Eluent: DCM/MeOH/Et2O 6:0.6:0.6. Left lane, purified 8;
co-spot of materials on left and right lanes; right lane, crude 8.

Figure A.38. 1H NMR of Ph(CH2)2O(PEG)12O(CH2)2Ph (8).
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Figure A.39. 13C NMR of Ph(CH2)2O(PEG)12O(CH2)2Ph (8).
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Figure A.40. LC-MS of Ph(CH2)2O(PEG)12O(CH2)2Ph (8).
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Ph(CH2)2O(PEG)20O(CH2)2Ph (9)

Figure A.41. TLC of crude 9. Eluent: DCM/MeOH/Et2O 6:0.6:0.6. Left lane, purified 9;
co-spot of materials on left and right lanes; right lane, crude 9.

Figure A.42. 1H NMR of Ph(CH2)2O(PEG)20O(CH2)2Ph (9).
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Figure A.43. 13C NMR of Ph(CH2)2O(PEG)20O(CH2)2Ph (9).
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Figure A.44. LC-MS of Ph(CH2)2O(PEG)20O(CH2)2Ph (9).
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Ph(CH2)2O(PEG)28O(CH2)2Ph (10)

Figure A.45. TLC of crude 10. Eluent: DCM/MeOH/Et2O 6:0.6:0.6. Left lane, purified
10; middle lane, co-spot of materials on left and right lanes; right lane, crude 10.

Figure A.46. 1H NMR of Ph(CH2)2O(PEG)28O(CH2)2Ph (10).
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Figure A.47. 13C NMR of Ph(CH2)2O(PEG)28O(CH2)2Ph (10).
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Figure A.48. LC-MS of Ph(CH2)2O(PEG)28O(CH2)2Ph (10).
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Ph(CH2)2O(PEG)36O(CH2)2Ph (11)

Figure A.49. TLC of crude 11. Eluent: DCM/MeOH/Et2O 6:0.6:0.6. Left lane, starting
material 10; middle lane, co-spot of materials on the left and right lanes; right lane, crude
11.

Figure A.50. 1H NMR of Ph(CH2)2O(PEG)36O(CH2)2Ph (11).
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Figure A.51. 13C NMR of Ph(CH2)2O(PEG)36O(CH2)2Ph (11).

Figure A.52. ESI-MS of Ph(CH2)2O(PEG)36O(CH2)2Ph (11).
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Ph(CH2)2O(PEG)44O(CH2)2Ph (12)

Figure A.53. TLC of crude 12. Eluent: DCM/MeOH/Et2O 6:1:1. Left lane, purified 12;
co-spot of materials on left and right lanes; right lane, crude 12.

Figure A.54. 1H NMR of Ph(CH2)2O(PEG)44O(CH2)2Ph (12).
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Figure A.55. 13C NMR of Ph(CH2)2O(PEG)44O(CH2)2Ph (12).

Figure A.56. HRMS of Ph(CH2)2O(PEG)44O(CH2)2Ph (12).
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